Lnk, an intracellular adapter protein, is expressed in hematopoietic cell lineages, which has recently been proved as an essential inhibitory signaling molecule for stem cell self-renewal in the stem cell factor-c-Kit signaling pathway with enhanced hematopoietic and osteogenic reconstitution in Lnk-deficient mice. Moreover, the therapeutic potential of hematopoietic stem/endothelial progenitor cells (EPCs) for fracture healing has been demonstrated with mechanistic insight into vasculogenesis/angiogenesis and osteogenesis enhancement in the fracture sites. We report here, Lnk siRNAtransfected endothelial commitment of c-kit þ /Sca-1 þ /lineage À subpopulations of bone marrow cells have high EPC colony-forming capacity exhibiting endothelial markers, VE-Cad, VEGF and Ang-1. Lnk siRNA-transfected osteoblasts also show highly osteoblastic capacity. In vivo, locally transfected Lnk siRNA could successfully downregulate the expression of Lnk at the fracture site up to 1 week, and radiological and histological examination showed extremely accelerated fracture healing in Lnk siRNA-transfected mice. Moreover, Lnk siRNA-transfected mice exhibited sufficient therapeutic outcomes with intrinstic enhancement of angiogenesis and osteogenesis, specifically, the mice demonstrated better blood flow recovery in the sites of fracture. In our series of experiments, we clarified that a negatively regulated Lnk system contributed to a favorable circumstance for fracture healing by enhancing vasculogenesis/angiogenesis and osteogenesis. These findings suggest that downregulation of Lnk system may have the clinical potential for faster fracture healing, which contributes to the reduction of delayed unions or non-unions.
Lnk shares a pleckstin homology domain, a Src homology 2 domain and potential tyrosine phosphorylation sites with APS and SH-2B. It belongs to a family of adaptor proteins implicated in the integration and regulation of multiple signaling events [1] [2] [3] [4] [5] and has also been suggested to act as a negative regulator in the stem cell factor (SCF)-c-Kit signaling pathway. 6 Takaki et al 7 reported that Lnk expressed in hematopoietic cell lineages, and bone marrow (BM) cells of Lnk-deficient mice are competitively superior in hematopoietic population to those of wild-type mice. Ema et al 8 also clarified that not only hematopoietic stem cell/ progenitor cell (HSC/HPC) numbers but also the selfrenewal capacity of some HSCs/HPCs were markedly increased in Lnk-deficient mice. In addition, the functional domains of Lnk were identified, and dominant-negative Lnk mutant inhibits the functions of Lnk endogenously expressed in the HSCs/HPCs and thereby potentiates the HPCs for engraftment. 9 In previous studies, we demonstrated that Lnk deletion reinforces the function of the BM progenitor, promoting repair of an injured spinal cord through the acceleration of angiogenesis and astrogenesis. 10 Another report suggested that Lnk regulated BM endothelial progenitor cells (EPCs) kinetics in vascular regeneration. Lnk-deficient EPCs are more potent actors than resident cells in hindlimb perfusion recovery and ischemic neovasucularization, mainly via the activity of BM EPCs. 11 Moreover, our group have recently demonstrated that a lack of Lnk signaling, dependent on SCF-cKit signaling pathway, enhanced a regenerative response via vasculogenesis and osteogenesis in fracture healing by HSC/EPC mobilization and recruitment to the fracture sites in Lnk-deficient mice. 12 Although most fractures heal appropriately in a certain period with callus formation, which bridges the fracture gap while bone repair takes place, a large number of patients with fractures waste a lot of time due to disability or confinement, leading to a tremendous loss of productivity. Moreover, a significant proportion (5-10%) of fractures fails to heal and results in delayed union or persistent non-union causing serious problems for a patient's quality of life. Therefore, establishment of a novel therapeutic strategy for non-union healing is clinically warranted. [13] [14] [15] [16] Among various causes of failed bone formation and remodeling, inappropriate neoangiogenesis is considered to be a crucial factor. 13, [16] [17] [18] The majority of tissues require appropriate vascularization and blood supply to support proper function. Without such vascularization, cells suffer from hypoxia, lack of nutrients, accumulation of waste products and disruption of biomechanical signaling pathways, affecting tissue homeostasis and preventing tissue regeneration. 19 Notably, appropriate vasculogenesis, by BM EPCs, 20, 21 is emerging as a prerequisite for bone development and regeneration, and indeed there appears to be a developmental reciprocity between endothelial cells (ECs) and osteoblasts (OBs). 22 We have recently proved the pathophysiological role and contribution of murine BM-derived Sca1 þ Lineage À cells, HSC/EPC-enriched fraction, for bone healing. 23 Therefore, the concept of enhanced angiogenesis/osteogenesis by HSCs/EPCs is emerging, and one of the novel factors responsible for stem/progenitor cell mobilization from BM, Lnk, seems to be attractive for developing a therapeutic strategy utilizing circulating EPCs for skeletal medicine. Aiming for the induction of neovascularization at the fracture sites, local downregulation of Lnk may provide a novel therapeutic strategy for modifying and improving the fracture healing process and preventing non-union.
In the present study, we examined the in vitro and in vivo properties of Lnk small interfering RNA (siRNA) and investigated the hypothesis that downregulation of Lnk signaling enhances a regenerative response via vasculogenesis/ angiogenesis and osteogenesis in fracture healing.
MATERIALS AND METHODS siRNA Preparation
The expression of Lnk was suppressed by RNA interference (RNAi) in mice c-kit þ /Sca-1 þ /Lineage À (KSL) cells, OBs and the tissues of a peri-fracture site. siRNAs were purchased from Dharmacon (Thermo Scientific, CO, USA) and HAYASHI KASEI. (Osaka, Japan) in deprotected, desalted and annealed forms. The sense strand sequences of the RNA duplexes were as follows: for mLnk No. 1 Preparation of Mouse KSLs (mKSLs) for In-Vitro Study To investigate the effect of Lnk siRNA on mouse ECs in vitro, we isolated the mouse endothelial commitment of KSL subpopulations of BM cells from 10-to 12-week-old mouse by a modification of a method reported previously. 24 BM cells were obtained from C57BL/6 mice (wild-type mice), and lineage-positive cells were removed using a magnetic cell separation system (BD IMag Hematopoietic Progenitor Cell Enrichment Set-DM; BD Biosciences, San Jose, CA, USA, http://www.bdbiosciences.com). In brief, cells isolated by centrifugation with a low-density solution (o1.077 g/ml) were stained with a mixture of biotinylated mouse lineage antibodies to CD3e, CD11b, CD45R/B220, Ly-6G and Ly-6C (Gr-1) and TER-119/erythroid cells (Ly-76). The lineagepositive cells were depleted with streptavidin-magnetic beads and the use of neodymium magnets (BD IMagnet; BD Biosciences). The remaining cells were collected and further stained with phycoerythrin-conjugated anti-Sca-1 and allophycocyanin-conjugated anti c-Kit antibodies. All antibodies were purchased from BD Biosciences. After washing, the cells were resuspended in staining medium supplemented with 7-amino-actinomycin D (7-AAD). Stained cells were analyzed by fluorescence-activated cell sorting using a BD FACSAria cell-sorting system (BD Biosciences), and KSL cells were sorted. Dead cells stained with 7-AAD were excluded from analysis and sorting.
Preparation of Mouse Osteoblasts (mOBs) for In-Vitro Study To investigate the effect of Lnk siRNA on mouse OBs in vitro, we isolated mouse calvarial OBs from 3-5-day-old C57BL/6 mouse calvarial bone using a modification of the method described previously. 25, 26 Briefly, after removal of sutures, calvaliae were subjected to 15-min digestions in an enzyme mixture containing 0.05% trypsin (Gibco, Life Technologies, CA, USA) and 1.5 U/ml collagenase P (Boehringer Mannheim, Mannheim, Germany) at 37 1C on a rocking platform. The enzyme activity was then neutralized by the addition of media containing FBS. The isolated cells were plated at a density of 1.5 Â 10 5 /mm 2 in 35-mm culture dish with 10% FBS/Dulbecco's modified Eagles' medium (DMEM). The cells were harvested and used for in vitro studies as mOBs after 2-3 weeks in culture.
were lysed for 10 min on ice. The supernatants were recovered by centrifugation at 15 000 g for 10 min to remove insoluble materials. The samples were mixed with 4 Â SDS sample buffer (0.25 M Tris-HCl (pH 6.8), 40% glycerol, 8% sodium dodecyl sulfate and 16% 2-mercaptoethanol), boiled for 5 min and loaded onto 0.1% SDS-10% polyacrylamide gel and run for 1 h at 150 V. After electrophoresis, proteins were transferred to nitrocellulose membranes in a Bio-Rad Electroblotter Apparatus. Membranes were blocked in PBST (PBS, 0.1% Tween-20) containing 2% blocking reagent for 30 min at room temperature and then reacted overnight at 4 1C with each antibodies: goat anti-Lnk antibody (M-20, sc-7222, Santa Cruz biotechnology, Santa Cruz, CA, USA), rabbit anti-BMP-2 antibody (ab82511, Abcam, Cambridge, MA, USA), rabbit anti-VE Cadherin antibody (ab33168, Abcam) and rabbit anti-b-tubulin antibody (Sigma, St Louis, MO, USA) as an internal control diluted 1:10 000 in PBSTblocking reagent. After three washes in PBST, the membranes were treated with affinity-purified horseradish peroxidaseconjugated donkey anti-goat IgG (Promega, Madison, WI, USA) and HRP-conjugated goat anti-rabbit IgG (GE Healthcare UK, UK) diluted 1:100 000. Membranes were washed three times in PBST and then developed with ECL Advance Kit (GE Healthcare UK). The images were obtained by luminescent image analyzer LAS-3000 (FUJIFILM). The densities of the blots were quantified using an image analysis software, ImageJ version (NIH Image). All values were normalized relative to Tublin expressions.
Immunoprecipitation
The proteins from the cell or tissue homogenate were prepared as described in western blotting method. The supernatants were pre-incubated with Protein G-agarose beads (Sigma) at 4 1C for 30 min to avoid non-specific protein absorption against agarose beads. The pre-incubated supernatants were mixed with goat anti-Lnk antibody for 1 h at 4 1C. The immune complex was then captured on a solid support by incubation with Protein G-agarose beads for 1 h at 4 1C followed by centrifugation and washing the pellets five times with PBS. Immunoprecipitated proteins were dissolved into SDS sample buffer and further analyzed by SDS-PAGE and immunoblotting to determine their molecular weights and to determine the presence and quantity of proteins.
EPC Colony-Forming Assay of Lnk and Control siRNATransfected KSL Cells EPC colony-forming assay established in our laboratory was performed as reported previously. 27, 28 The number of EPC colonies was assessed 16 days after seeding of Lnk siRNA and control siRNA-transfected KSL cells (1 Â 10 3 cells/well) in a six-well plate with methyl cellulose-containing medium M3236 (Stem Cell Technologies, Vancouver, BC, Canada) supplemented with 20 ng/ml SCF (Kirin, Tokyo, Japan), 50 ng/ml VEGF (R&D Systems, Minneapolis, MN), 20 ng/ml interleukin-3 (Kirin) and 50 ng/ml basic fibroblast growth factor (Wako, Osaka, Japan). Two different types of attaching cell colonies made of small EPCs and large EPCs were counted separately.
Induction of Osteogenic Differentiation in vitro
To induce osteogenic differentiation, 100 000 Lnk siRNA and control siRNA-transfected OBs were plated in six-well plates and cultured for 3 weeks under specific osteogenic conditions in alpha-MEM supplemented with 10% FBS, 2 mM L-glutamine, 60 mM ascorbic acid (Sigma-Aldrich, St Louis, MO, USA), 10 mM beta-glycerophosphate (Sigma-Aldrich) and 0.1 mM dexamethasone (Sigma-Aldrich). Cells were also cultured with alpha-MEM supplemented with 10% FBS and 2 mM L-glutamine as a negative control.
Proliferation and Migration Assays for Cultured Mouse KSLs and OBs
The proliferation activity of mEPCs and mOBs in the presence of Lnk siRNA and control siRNA was examined using a Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan) according to the manufacturer's instructions. Briefly, Lnk and control siRNA were transfected into mouse KSL cells and OBs by lipofection according to the manufacturer's instructions. Twenty-four hours after transfection, the siRNA-transfected KSL cells or OBs were seeded onto 96-well culture plates at a density of 5 Â 10 3 cells per well and cultured in EBM2 or DMEM with 10% FBS for 48 h at 37 1C in 20% O 2 /5% CO 2 . Optical density was measured using a plate reader at 490 nm wavelength.
Migration activity was evaluated with a modified Boyden's chamber assay as described previously. 29 Mouse KSLs or OBs (5 Â 10 4 cells per well) were seeded onto upper chambers in 24-well Transwell culture plates (Corning Incorporated Life Science, MA, USA) and lower chambers were filled with DMEM with 10% FBS containing 50 ng/ml of SDF-1a (Minneapolis, MN, USA) followed by incubation for 6 h at 37 1C in 5% CO 2 . Migrated cells were stained with 4',6-diamidino-2-phenylindole (DAPI) and counted under a fluorescent microscope. All groups were studied at least in triplicate.
Histochemical Analysis of Cell Cultures
Mineralization was assessed by alizarin red staining method. Briefly, the cultures were rinsed twice with PBS, fixed in 100% ethanol for 30 min and stained with 1% Alizarin Red S (Hartman Leddon, Philadelphia, PA, USA) in 0.28% ammonia water for 10 min at room temperature. The stained cell layers were washed twice with distilled water and air-dried for micro/macroscopic observation. For quantification, Alizarin Red dye was extracted from the stained cell layer with 5% formic acid solution, and the optical density was measured by a photometer (Microplate leader Model 680, Bio-Rad, Tokyo, Japan) at 415 nm wavelength. 
Mice Animal Model of Bone Fracture
Male mice (C57BL/6, CLEA Japan, Tokyo, Japan) aged 10-12 weeks and weighing 25-27 g were used in this study. The mice were fed a standard maintenance diet and provided water ad libitum. All animal procedures were performed in accordance with the Japanese Physiological Society Guidelines for the Care and Use of Laboratory Animals, and the study protocol was approved by the Ethical Committee of the RIKEN Center for Developmental Biology.
All surgical procedures were performed under anesthesia and normal sterile conditions. Anesthesia was performed with ketamine hydrochloride (60 mg/kg) and xylazine hydrochloride (10 mg/kg) administered intraperitoneally. A reproducible bone fracture model was created in the femur of the mice, according to a modification of Manigrasso's mode. 30 A lateral parapatellar knee incision on the right limb was made to expose the distal femoral chondyle. A 2-mm wedge was made using a 27-gauge needle on the interchondyle of the femur and then a 0.5-mm diameter, stainless wire was inserted in a retrograde fashion. The wire was advanced until its proximal end was positioned stable to the greater trochanter, and the distal end was cut close to the articular surface of the knee. A transverse femoral shaft fracture was then created in the right femur of each mouse. The wound was then irrigated with 10 cc of sterile saline, and the skin was closed in layers with 5-0 nylone sutures. Unprotected weight bearing was allowed immediately postoperatively. The left non-fractured femur served as a control.
Local Transplantation of siRNA and the Experimental Groups Immediately after creation of fracture, mice received local administration of the following materials mixed in 100 ml of AteloGene atelocollagen gel (KOKEN, Tokyo, Japan), which was used as a bio-absorbable scaffold to retain the siRNA at the transplantation site: 31, 32 (1) 10 mM Lnk siRNA (Lnk group), and (2) 10 mM control scramble siRNA (control group). Twenty animals were assigned in each group for radiological assessment and every additional three or five animals in each group were assigned in each study. The contralateral intact femurs were used as controls for histological and functional analyses.
Tissue Harvesting
Mice were euthanized with an overdose of ketamine and xylazine for biomechanical and histological analyses at the indicated time course described below. The femurs were directly frozen for biomechanical analysis, embedded in OCT compound (Sakura Finetek Japan) for histological analysis and snap frozen in liquid nitrogen and stored at À 80 1C for real-time RT-PCR analysis. Three mice were randomly selected and euthanized in each group at weeks 1, 2 and 3 after surgery. The remaining rats were killed at week 4. Bilateral femurs were harvested and quickly treated for the above mentioned analyses as described previously. 33, 34 after the first-strand cDNA was synthesized using a RNA LA PCR Kit Ver1.1 (TAKARA BIO, Shiga, Japan), the converted cDNA samples (2 ml) were amplified in triplicate by real-time PCR (ABI PRISM 7700, Applied Biosystems, Foster City, CA, USA) in a final volume of 20 ml using SYBR Green Master Mix reagent (Applied Biosystems) with gene-specific primers listed in Table 1 . Melting curve analysis was performed with Dissociation Curves Software (Applied Biosystems). Results were obtained using sequence detection software (ABI PRISM 7700) and the mean cycle threshold (Ct) values were used to calculate gene expressions with normalization to human or rat glyceraldehydes-3-phosphate (GAPDH).
Morphometric Evaluation of Capillary Density and OB Density
To evaluate capillary density and OB density at the perifracture sites, immunohistochemistry was performed with the following anti-mouse rat CD31 (1:50 dilution, Santa Cruz Biotechnology) as a sensitive marker for mice ECs, or anti-mouse goat OC (1:250 dilution, Biogenesis) a marker for mice OBs. The secondary antibodies for each immunostaining are as follows: Alexa-Fluor 488-conjugated goat anti-rat IgG (1:1000, Invitrogen, CA, USA) for CD31 and Alexa-Fluor 594-conjugated donkey anti-goat IgG (1:1000, Invitrogen, CA, USA) for OC. DAPI solution (1:5000, Sigma-Aldrich) was applied for 5 min for nuclear staining. The capillary and OB density was morphometrically evaluated as average values in five randomly selected fields in the soft tissue of peri-fracture sites under a fluorescent microscope. Capillaries were recognized as tubular structures positive for CD31. OB-like cells were recognized as lining or floating cells positive for OC on new bone surface. All morphometric studies were performed by two examiners who were blinded to treatment.
Double Immunofluorescent Staining
To detect Lnk expressing BM progenitor cells in the mouse peri-fracture sites, immunohistochemistry was performed with the following antibodies: Lnk (C-20) (1:50 dilution, Santa Cruz Biotechnology) and anti-mouse CD117, cKit (1:100 dilution, Chemicon, Millipore, Burlingame, Billerica, MA) as a sensitive marker for immature BM progenitor cells. The used secondary antibodies for each immunostaining were as follows: Alexa Fluor 594-conjugated donkey anti-goat IgG 1 (1:500, Invitrogen, CA, USA) for mLnk, Alexa Fluor 488-conjugated goat anti-rat IgG 1 (1:500, Molecular Probes, Invitrogen Japan K.K., Tokyo, Japan) for mCD117. DAPI solution (1:500, Sigma-Aldrich) was applied for 5 min for nuclear staining.
Physiological Assessment for Blood Perfusion by Laser Doppler Imaging (LDPI) LDPI system (Moor Instrument, Wilmington, DE, USA) 35, 36 was used to measure serial blood flow in both hindlimbs at 0, 1, 2 and 3 weeks post fracture according to the manufacturer's instruction. The ratio of fractured/intact contralateral blood flow was calculated to evaluate the serial blood flow recovery after surgery.
In these digital color-coded images, a red hue indicated regions with maximum perfusion, medium perfusion values were shown in yellow and the lowest perfusion values were represented as blue. The measurement was performed under anesthesia with animals supine and both limbs fully extended. At first, we palpated the femoral fracture site under the skin and pasted a small stainless steel marker on the skin above the fracture site. The steel marker was scanned as a defect spot in the LDPI image, and was recognized as the center of the region of interest (ROI). The steel marker was removed and scanned again. Then, the ROI squares on the second scanned image referring to the first image were set with the marker's defect spot. The blood flow recovery following fracture was evaluated as the ratio of mean flux within the ROI in the fractured hindlimb to the same size ROI in the contralateral intact hindlimb.
Radiographic Assessment for Fracture Healing
Radiographs of the fractured hindlimbs were serially taken at weeks 0, 1, 2, 3 and 4 following creation of fractures under anesthesia with the animals supine and both limbs fully extended. Fracture union was identified by the presence of a bridging callus on two cortices. Radiographs in each animal were examined by three blinded observers.
For quantification of callus/trabecular bone formation, micro-computed tomography (CT) imaging analysis was performed 3 weeks after fracture creation using LaTheta (ALOKA, Tokyo, Japan). To evaluate the fracture healing process, relative callus areas around the fracture sites in scanned radiographs at week 3 were quantified using LaTheta. Bone densities in the callus areas were calculated with CT intensity in scanned images by single-energy X-ray absorptiometry method and averaged using LaTheta. To recognize fracture healing more clearly, three-dimensional CT images were reconstructed using Volume Graphics GmbH Studio MAX software (Heidelberg, Germany).
Histological Assessment of Fracture Healing
Histological evaluations (n ¼ 3 in each group) were performed with toluidine blue staining to address the process of endochondral ossification at weeks 1, 2 and 3. The degree of fracture healing was evaluated using a five-point scale (grade 0-4) proposed by Allen et al. 37 Samples were sectioned at siRNA targeting Lnk Y Kawakami et al 6-mm thickness on slides followed by fixation with 4% paraformaldehyde at 4 1C for 5 min. All morphometric studies were performed by two orthopedic surgeons blinded to the treatment.
Biomechanical Analysis of Fracture Union
Three mice in each treatment group were used for biomechanical evaluation at week 4 post fracture. Biomechanical evaluation was performed in Kureha Special Laboratory (KSL, Tokyo, Japan). Fractured femurs and contralateral nonfractured femurs were prepared and intramedullar fixation pins were removed before the bending test. The standardized three-point bending test was performed using a load torsion and bending tester 'MZ-500S' (Maruto Instruments, Tokyo, Japan). The bending force was applied with cross-head at a speed of 2 mm/min until rupture occurred. The extrinsic stiffness (N/mm) and the ultimate stress (N) were interpreted and calculated from the load deflection curve. The relative ratio of the fractured (right) femur to non-fractured (left) femur was calculated in each group and averaged.
Statistical Analysis
The results were statistically analyzed using a software package (Graph Pad Prism, MDF software). All values were expressed as mean±s.e.m. Paired t-test were performed for comparison before and after fracture. Unpaired t-tests (Mann-Whitney U-test) were performed for comparison between the two groups. The comparison of radiological results was performed with a w 2 -test. A probability value of o0.05 was considered to denote statistical significance. Figure 1c) .
RESULTS
Following osteogenic induction, Lnk siRNA-transfected OBs exhibited remarkable matrix mineralizations as assessed by Alizarin Red staining for calcium detection (Figure 2a ). Lnk siRNA-transfected OBs showed a significant high concentration of Alizarin Red dye compared with the control siRNAtransfected OBs (Figure 2b ). In addition, mRNAs of mOC, mBMP-2, mCol1A1, mRunx2 and mALP were highly expressed significantly in Lnk siRNA group than the control siRNA group after osteogenic induction. These results suggest that KSL cells and OBs were functionally activated by Lnk gene deletion.
Fracture Upregulates Lnk gene Expression at PeriFracture site. We first compared the frequency of Lnk mRNA expression by real-time RT-PCR analysis in the sites of peri-fracture and BM at the indicated time course (Figure 3a) . We collected The relative expressions of Lnk mRNA to GAPDH mRNA were significantly upregulated in both the BM (Figure 3b ) and peri-fracture site (Figure 3c) Figure S1E) . Next, to determine what specific type of cells express Lnk in the sites of fracture, we performed double immunostaining of c-Kit for immature progenitors and Lnk with the samples 5 days after fracture creation. We detected Lnk-expressing immature c-Kit þ cells at the peri-fracture site 1 week after fracture creation (Figures 3d and e) ; however, no Lnk expressed cells were observed in the samples obtained 2 and 4 weeks after surgery.
Lnk Gene Deletion Accelerates Fracture Healing
The results of western blotting with tissue samples collected on days 3, 5 and 7 post fracture demonstrated that Lnk expression was significantly decreased in the Lnk siRNA-transfected mice. We also confirmed that Lnk expression was suppressed in the peri-fracture site up to 1 week after Lnk siRNA-conjugated atelocollagen transplantation. (Figures 3f-i) .
Next, to evaluate fracture repair morphologically, radiographical and histological examinations were performed. Fractures were united radiographically with bridging callus formation in 60% (12 out of 20) of the Lnk group mice at week 2 and 90% (18 out of 20) at week 3. In contrast, fracture sites in all the animals of the control group showed only 30% (6 out of 20) fracture healing at week 2 and 60% (12 out of 20) at week 3 (Po0.05 in week 2 and 3). The time course of union rate in each group is described in Supplementary  Figure S2A . Morphological and functional fracture healing in each group was further evaluated by micro-CT 3 weeks after fracture surgery. The results of micro-CT exhibited striking trabecular bone formation in the Lnk group compared with the control group (Figure 4a, Supplementary Figure S2B) . Quantitative analysis for bone formation was performed using micro-CT images and expressed as callus volume and bone density, trabecular width and number of trabeculae. Figures 4b-e) . Fracture healing was also histologically evaluated by toluidine blue staining. In animals receiving Lnk siRNA, bridging callus formation was observed at week 2, and finally fractures were united completely at week 3. In the control group, although callus formation was observed, bridging callus formation was rarely found at week 2 ( Figure 4h ). The score of fracture healing assessed by Allen's classification 38 was significantly higher in the Lnk group compared with control group at weeks 2 and 3. week 2: Lnk 2.60 ± 0.245 vs control 1.40 ± 0.245, Po0.05; week 3: Lnk 3.80±0.20 vs 2.60±0.400 Po0.05, n ¼ 3; Figure 4i ).
These results clearly indicate that the femoral fracture could be quickly repaired by local Lnk gene silencing.
Lnk siRNA Transplantation Leads to Functional Bone Healing after Fractures
To confirm functional recovery of the fractured bones, biomechanical evaluation by a three-point bending test was performed at week 4 in both the groups (n ¼ 3 in each group). There was no significant difference of the specimen length between the Lnk group and control group. (Figures 4f and g ). These findings indicate that fractures are not only radiographically but also functionally repaired by local Lnk gene silencing.
Lnk siRNA Transfection Enhanced Intrinsic Angiogenesis and Osteogenesis in the Sites of Fracture
We confirmed enhanced angiogenesis and osteogenesis by Lnk siRNA transfection at the peri-fracture sites' tissues by immunostaining with specific markers for EC and OB. Immunohistochemical vascular staining with CD31, a marker for EC, in tissue samples collected 1 week post fracture, demonstrated enhancement of intrinsic neovascularization around the endochondral ossification area in animals treated with Lnk siRNA (Figure 5a ). Neovascularization assessed by capillary density was significantly greater in the Lnk siRNA group compared with the control siRNA group. (Lnk, 250.2±10.97 vs control, 162.2±9.98/mm 2 , Po0.001, n ¼ 3; Figure 5b ).
OB staining with anti-mouse OC on tissue samples collected 1 week post fracture revealed the augmentation of osteogenesis in a newly formed bone area in the Lnk group compared with the control group (Figure 5d Figure 5h ). These results indicate that the morphological enhancement of angiogenesis and osteogenesis were attributed to Lnk gene deficiency in fracture-induced environment.
Lnk siRNA Transfection Promotes Blood Flow Recovery at the Sites of Fracture
To evaluate blood flow recovery via neovascularization at the fracture sites, LDPI was serially performed after fracture creation (Figure 6a) . In both the groups, severe reduction of blood flow was observed 1 h after fracture. There was no significant difference in the blood flow ratio of fractured to intact hindlimbs 1 h after fracture between the two groups. Although the blood perfusion ratios were significantly higher in the Lnk group than in the control group at week 1 (Lnk, 1.30 ± 0.04 vs control, 1.12 ± 0.04/mm 2 , Po0.05, n ¼ 3), a similar trend was observed until 2 weeks after surgery (Lnk, 1.45 ± 0.06 vs control, 1.10 ± 0.03/mm 2 , Po0.05, n ¼ 3). At week 3, the blood flow ratio exhibited no significant difference between the two groups (Figure 6b Supplementary Figures S3C and D) . We also checked the above gene expresssions not only in the peri-fracture site but also in the BM; however, there were no statistical differences between the groups (data not shown), perhaps because Lnk gene expression was absent in the BM 7 days aftrer fracture (Figure 3f ). These results suggest that Lnk siRNA might enhance not only intrinsic angiogenesis but also osteogenesis at the fracture sites paracrinely via upregulation of pro-angiogenic and -osteogenic cytokines, leading to accelerated fracture healing with blood perfusion recovery.
DISCUSSION
In our series of experiments, we clarified that a negatively controlled Lnk system, using an atelocollagen-based siRNA transfection technique, contributed to a favorable environment for fracture healing by promoting vasculogenesis and osteogenesis at fracture sites, leading to rapid Lnk deletion has been shown to not only increase cell numbers but also reinforce self-renewal function of HSC/ HPC and neural stem cells. 8, 10, 38 In this study, we have demonstrated that Lnk was also expressed in KSL cells and OBs, and Lnk siRNA-transfected KSL cells and OBs showed increased proliferation activity and high vasculogenic and osteogenic activity. In vivo study, we demonstrated that c-Kit positive BM-derived progenitor cells co-expressed Lnk in a fracture-induced environment at the initial phase in the fracture repair process. Moreover, we have also demonstrated that local downregulation of Lnk enhanced bone healing at the fracture site in the in vivo study. These findings are thought to be caused by the following two mechanisms. First, osteogenesis and vasculogenesis closely regulate each other in terms of microenvironmental interaction for regenerative activity in BM. It has been reported that BM side population cells, which contain hematopoietic repopulating cells, can also engraft in the bone after transplantation 39 and that the non-adherent population of BM cells, including KSL cells, contains primitive cells able to generate both hematopoietic and osteocytic lineage cells. 40 Kwon et al 11 reported that Lnkdeficient EPCs (KSLs) are more potent in BM-EPC kinetics, including the ability of cell growth, endothelial commitment, mobilization and recruitment for vascular regeneration. Calvi et al 41 also found a parallel expansion of HSCs when the number of OBs was increased by parathyroid hormone infusion. Second, BMP-2-involved SCF-cKit signaling pathway is thought to be involved in the promotion of OB activity by silencing Lnk gene. Indeed, Matsumoto et al 12 previously demonstrated that upregulation of BMP-2 mRNA expression was greater in the Lnk knockout mice than that in the wild-type mice and that a lack of Lnk or SCF supplement in OBs induced terminal differentiation of OBs and mineralized matrix formation with increased BMP-2 gene expression at the sites of fracture that were blocked by SCF antagonist. In the current study, the favorable effects of Lnk siRNA transfection on fractures were evidenced by a series of assessments in fracture healing. In the Lnk siRNA-transfected mice, quantitative histochemical analysis for ECs and OBs revealed the enhancement of angiogenesis and osteogenesis at the sites of fracture, leading to superiority of functional blood flow recovery and callus formation, and quantitative realtime RT-PCR analyses also exhibited upregulation of proangiogenic/-osteogenic gene expressions which is consistent with increased blood perfusion and callus formation at the peri-fracture sites. Regarding pro-angiogenic gene expression, the discrepancy between significant upregulation of mVEGF mRNA expression in KSL cells (Figure 1b) and no significant upregulation of mVEGF mRNA expression in peri-fracture tissue (Figure 7d ) is attributed by sampling time course difference of 24 h after Lnk siRNA transfection in KSL cells vs 7 days after Lnk siRNA transfection. The series of findings could support the evidence that fractures promptly heal with sufficient mineralization and stiffness in the Lnk siRNA-transfected mice compared with control mice.
Silencing gene expression by siRNA is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA and the limitation of its action call for an efficient delivery technology. In the past studies, several groups have described the use of viral vectors for siRNA delivery. [42] [43] [44] However, viral vectors suffer from a problem of promoting side effects. Although the 'hydrodynamic transfection method' and a liposome transfection method were recently reported for siRNA delivery into animals, 45, 46 more practical methods are needed for clinical use. Therefore, the development of safe and effective non-vector-based siRNA delivery systems is critical for the future of siRNA-based therapies. Recent reports described that atelocollagen complexed with siRNA is resistant to nucleases and is efficiently transduced into cells, thereby allowing long-term gene silencing. 31, 47 Here, we used an atelocollagen-mediated siRNA transfer in an in vivo fracture model and could negatively control Lnk at the fracture site. Because atelocollagen allowed increased cellular uptake, nuclease resistance and prolonged release of siRNAs, atelocollagen complexed with siRNA rather than siRNA alone resulted in stronger gene silencing effects compared with other methods. As atelocollagen has an ability to transfer genes to both dividing and non-dividing cells, the atelocollagen-based siRNA transfer system represents an ideal method for achieving maximal outcome of siRNAbased gene silencing in vivo.
Despite the promising initial results obtained with Lnk siRNA transfection for fracture repair, there is a certain issue that needs to be solved before we move to clinical application. For instance, although recent reports described that atelocollagen complexed with siRNA was efficiently transduced into cells allowing long-term gene silencing not only in vivo but also in vitro, 31, 47 we have a persistent concern that unexpected outcome will occur in other type of cells by longterm Lnk deletion. Indeed, previous reports suggest that Lnk is a negative regulator of brain neural stem cell proliferation and Lnk deficiency partially mitigates hematopoietic stem cell aging. 38, 48 Nevertheless, our data shown in this study clearly indicate that downregulation of Lnk system promoted fracture healing.
In our series of experiments, we clarified that a negatively controlled Lnk system contributed to a favorable environment for fracture healing by enhancing vasculogenesis/ angiogenesis and osteogenesis, leading to rapid bone reconstitution from fracture. The current study revealed the therapeutic potential of Lnk siRNA when transfected with a siRNA targeting Lnk Y Kawakami et al bioabsorbable scaffold, atelocollagen, at the sites of fracture in a mouse model. Therefore, downregulation of Lnk system may have a clinical impact for fast fracture healing that contributes to the reduction of delayed union or non-union fracture.
